$MLAB News

Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth

Mesa Laboratories Plans Restructuring Program To Cut Annual Operating Costs By ~$9.3M; Expects Pre-Tax Charges Of ~$2.6M - $3.4M In H2 FY27; Saving Plan To Be Fully Reflected In Annualized Cost Structure By End Of FY28

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110

Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary

Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ...

Mesa Laboratories Q1 Earnings Call Highlights

Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript

Mesa Labs Announces First Quarter Results

UPDATE: Mesa Laboratories Q1 Adj. EPS $2.68 Beats $2.40 Estimate, Sales $60.138M Miss $60.867M Estimate

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Laboratories: Priced for the Problem, Not the Platform

Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today

Mesa Labs (NASDAQ:MLAB) Delivers Mixed Q4 Results as EPS Surges Past Estimates but Revenue Falls Short

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

Mesa Laboratories Q4 Adj. EPS $3.30 Beats $0.34 Estimate, Sales $63.724M Miss $65.171M Estimate

Mesa Laboratories: Hard To Set The Right Diagnosis